| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | malic enzyme activity | 7.03e-07 | 4 | 113 | 3 | GO:0004470 | |
| GeneOntologyMolecularFunction | malate dehydrogenase activity | 9.68e-06 | 8 | 113 | 3 | GO:0016615 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 5.56e-05 | 37 | 113 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 6.19e-05 | 38 | 113 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | plus-end directed microfilament motor activity | 9.49e-05 | 3 | 113 | 2 | GO:0060002 | |
| GeneOntologyMolecularFunction | malate dehydrogenase (decarboxylating) (NADP+) activity | 9.49e-05 | 3 | 113 | 2 | GO:0004473 | |
| GeneOntologyMolecularFunction | oxaloacetate decarboxylase activity | 1.89e-04 | 4 | 113 | 2 | GO:0008948 | |
| GeneOntologyMolecularFunction | NAD binding | 7.84e-04 | 73 | 113 | 4 | GO:0051287 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERVK-6 SMG1 DDR2 OBSCN DGKD ERVK-7 SIRT4 ITPKB DSTYK PRKAG1 TNKS POLD3 WNK3 ALPK2 | 8.37e-04 | 938 | 113 | 14 | GO:0016772 |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 1.11e-03 | 9 | 113 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.29e-03 | 38 | 113 | 3 | GO:0034061 | |
| GeneOntologyBiologicalProcess | malate metabolic process | 1.31e-05 | 9 | 113 | 3 | GO:0006108 | |
| MousePheno | abnormal double-strand DNA break repair | 4.35e-06 | 70 | 86 | 6 | MP:0010948 | |
| Domain | Coatomer_g_Cpla | 3.25e-05 | 2 | 107 | 2 | IPR032154 | |
| Domain | - | 3.25e-05 | 2 | 107 | 2 | 2.60.40.1480 | |
| Domain | COP-gamma_platf | 3.25e-05 | 2 | 107 | 2 | PF08752 | |
| Domain | Coatomer_g_Cpla | 3.25e-05 | 2 | 107 | 2 | PF16381 | |
| Domain | Coatomer_gsu_app_Ig-like-sub | 3.25e-05 | 2 | 107 | 2 | IPR013040 | |
| Domain | Coatomer_gsu | 3.25e-05 | 2 | 107 | 2 | IPR017106 | |
| Domain | Malic_OxRdtase | 9.72e-05 | 3 | 107 | 2 | IPR001891 | |
| Domain | Malic_NAD-bd | 9.72e-05 | 3 | 107 | 2 | IPR012302 | |
| Domain | Malic_N_dom | 9.72e-05 | 3 | 107 | 2 | IPR012301 | |
| Domain | MALIC_ENZYMES | 9.72e-05 | 3 | 107 | 2 | PS00331 | |
| Domain | Malic_M | 9.72e-05 | 3 | 107 | 2 | PF03949 | |
| Domain | Malic_M | 9.72e-05 | 3 | 107 | 2 | SM00919 | |
| Domain | malic | 9.72e-05 | 3 | 107 | 2 | PF00390 | |
| Domain | - | 9.72e-05 | 3 | 107 | 2 | 3.40.50.10380 | |
| Domain | malic | 9.72e-05 | 3 | 107 | 2 | SM01274 | |
| Domain | Malic_enzyme_CS | 9.72e-05 | 3 | 107 | 2 | IPR015884 | |
| Domain | ARM-like | 1.63e-04 | 270 | 107 | 8 | IPR011989 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 1.94e-04 | 4 | 107 | 2 | IPR015873 | |
| Domain | - | 1.94e-04 | 4 | 107 | 2 | 3.30.310.30 | |
| Domain | ARM-type_fold | 7.44e-04 | 339 | 107 | 8 | IPR016024 | |
| Domain | Coatomer/calthrin_app_sub_C | 8.90e-04 | 8 | 107 | 2 | IPR009028 | |
| Domain | IQ | 1.21e-03 | 81 | 107 | 4 | SM00015 | |
| Domain | - | 1.76e-03 | 222 | 107 | 6 | 1.25.10.10 | |
| Domain | IQ_motif_EF-hand-BS | 1.78e-03 | 90 | 107 | 4 | IPR000048 | |
| Domain | Coatomer/clathrin_app_Ig-like | 2.07e-03 | 12 | 107 | 2 | IPR013041 | |
| Domain | Clathrin/coatomer_adapt-like_N | 3.25e-03 | 15 | 107 | 2 | IPR002553 | |
| Domain | Adaptin_N | 3.25e-03 | 15 | 107 | 2 | PF01602 | |
| Domain | A/G_cyclase_CS | 4.18e-03 | 17 | 107 | 2 | IPR018297 | |
| Domain | LH2 | 4.69e-03 | 18 | 107 | 2 | SM00308 | |
| Domain | - | 4.69e-03 | 18 | 107 | 2 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 4.69e-03 | 18 | 107 | 2 | IPR029787 | |
| Domain | Guanylate_cyc | 5.22e-03 | 19 | 107 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 5.22e-03 | 19 | 107 | 2 | PS50125 | |
| Domain | A/G_cyclase | 5.22e-03 | 19 | 107 | 2 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 5.22e-03 | 19 | 107 | 2 | PS00452 | |
| Domain | CYCc | 5.22e-03 | 19 | 107 | 2 | SM00044 | |
| Pubmed | NRIP1 RAPGEF6 ACACB COPG2 ZNF217 ZNF318 MDH1 YEATS2 GTF3C1 BRCA2 PLEKHA2 | 1.41e-07 | 418 | 114 | 11 | 34709266 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 3.41e-07 | 5 | 114 | 3 | 12629516 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 1.44e-06 | 168 | 114 | 7 | 30631154 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.38e-06 | 123 | 114 | 6 | 26912792 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAPGEF6 SETX GLCCI1 ITPKB FSIP2 CASKIN2 DSTYK PLEKHA2 DOCK6 HECTD1 SH3RF3 FOXK1 WNK3 | 5.21e-06 | 861 | 114 | 13 | 36931259 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SECISBP2L RAPGEF6 COPG1 RBM33 NOC2L MYO10 COPG2 FCHO2 NEDD1 GLCCI1 TNKS POLD3 DOCK6 FOXK1 | 7.99e-06 | 1038 | 114 | 14 | 26673895 |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.07e-05 | 2 | 114 | 2 | 9460924 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 33619771 | ||
| Pubmed | Functional roles of the tetramer organization of malic enzyme. | 1.07e-05 | 2 | 114 | 2 | 19416979 | |
| Pubmed | Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome". | 1.86e-05 | 16 | 114 | 3 | 29878059 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NRIP1 SETX RBM33 ZNF217 ZNF318 YEATS2 BRCA2 BANP DDX20 FOXK1 | 2.49e-05 | 588 | 114 | 10 | 38580884 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NRIP1 OBSCN NEDD1 ZNF595 TASOR2 ITPKB YEATS2 GTF3C1 GUCY1A1 BANP SFXN3 PRKAG1 PLEKHA2 DOCK6 HECTD1 SH3RF3 | 2.90e-05 | 1489 | 114 | 16 | 28611215 |
| Pubmed | MAGEB2 RBM33 NEDD1 YEATS2 MDC1 BANP DDX20 CEP295 PRR14L POLD3 HECTD1 | 3.05e-05 | 733 | 114 | 11 | 34672954 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 10516026 | ||
| Pubmed | Changes in protein expression due to deleterious mutations in the FA/BRCA pathway. | 3.19e-05 | 3 | 114 | 2 | 17977515 | |
| Pubmed | Interaction of gamma-COP with a transport motif in the D1 receptor C-terminus. | 3.19e-05 | 3 | 114 | 2 | 11893085 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 5.25e-05 | 398 | 114 | 8 | 35016035 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.36e-05 | 4 | 114 | 2 | 10469592 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 5496232 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 7983737 | ||
| Pubmed | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. | 9.47e-05 | 27 | 114 | 3 | 23027611 | |
| Pubmed | 1.06e-04 | 74 | 114 | 4 | 15031102 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.06e-04 | 5 | 114 | 2 | 11401426 | |
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 23038782 | ||
| Pubmed | A hydride transfer complex reprograms NAD metabolism and bypasses senescence. | 1.06e-04 | 5 | 114 | 2 | 34547241 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.12e-04 | 444 | 114 | 8 | 34795231 | |
| Pubmed | 1.17e-04 | 332 | 114 | 7 | 37433992 | ||
| Pubmed | Tankyrases Promote Homologous Recombination and Check Point Activation in Response to DSBs. | 1.58e-04 | 6 | 114 | 2 | 26845027 | |
| Pubmed | Identification and characterization of novel isoforms of COP I subunits. | 1.58e-04 | 6 | 114 | 2 | 11056392 | |
| Pubmed | 1.58e-04 | 6 | 114 | 2 | 15063128 | ||
| Pubmed | 1.58e-04 | 6 | 114 | 2 | 11884415 | ||
| Pubmed | Multiple roles of FOXJ3 in spermatogenesis: A lesson from Foxj3 conditional knockout mouse models. | 1.59e-04 | 32 | 114 | 3 | 27739607 | |
| Pubmed | 1.91e-04 | 34 | 114 | 3 | 12086465 | ||
| Pubmed | Elongator and codon bias regulate protein levels in mammalian peripheral neurons. | 2.21e-04 | 7 | 114 | 2 | 29497044 | |
| Pubmed | 2.61e-04 | 638 | 114 | 9 | 31182584 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 2.66e-04 | 94 | 114 | 4 | 21542922 | |
| Pubmed | SMG1 ACACB UNCX NOC2L DPPA2 CAGE1 ZNF318 RYR2 TASOR2 OR10G4 GTF3C1 UNC5C CEP295 G6PC2 | 2.71e-04 | 1442 | 114 | 14 | 35575683 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAPGEF6 KIF26A MYO10 RTTN OBSCN BMP4 BANP MAPKBP1 DOCK6 HECTD1 ALOX5 FOXK1 | 2.81e-04 | 1105 | 114 | 12 | 35748872 |
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 8940050 | ||
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 20810650 | ||
| Pubmed | Novel isotypic gamma/zeta subunits reveal three coatomer complexes in mammals. | 2.94e-04 | 8 | 114 | 2 | 14729954 | |
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 17473173 | ||
| Pubmed | SECISBP2L SMG1 RAPGEF6 SETX MYO19 GTF3C1 CASKIN2 SUPV3L1 DSTYK | 2.99e-04 | 650 | 114 | 9 | 38777146 | |
| Pubmed | 3.09e-04 | 653 | 114 | 9 | 22586326 | ||
| Pubmed | 3.41e-04 | 396 | 114 | 7 | 26687479 | ||
| Pubmed | 3.65e-04 | 529 | 114 | 8 | 14621295 | ||
| Pubmed | 3.78e-04 | 9 | 114 | 2 | 32345962 | ||
| Pubmed | A single binding site for dilysine retrieval motifs and p23 within the gamma subunit of coatomer. | 3.78e-04 | 9 | 114 | 2 | 9751720 | |
| Pubmed | COP I domains required for coatomer integrity, and novel interactions with ARF and ARF-GAP. | 3.78e-04 | 9 | 114 | 2 | 10921873 | |
| Pubmed | Comparative mapping in the beige-satin region of mouse chromosome 13. | 4.71e-04 | 10 | 114 | 2 | 9027500 | |
| Pubmed | SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase. | 4.71e-04 | 10 | 114 | 2 | 19720090 | |
| Pubmed | 4.71e-04 | 10 | 114 | 2 | 12970426 | ||
| Pubmed | Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network. | 5.01e-04 | 111 | 114 | 4 | 32683582 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETX COPG1 NOC2L MYO19 DGKD GTF3C1 SUPV3L1 MDC1 A2ML1 SFXN3 DDX20 PRR14L POLD3 | 5.01e-04 | 1353 | 114 | 13 | 29467282 |
| Pubmed | Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. | 5.35e-04 | 113 | 114 | 4 | 23403292 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 5.75e-04 | 11 | 114 | 2 | 20427287 | |
| Pubmed | Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis. | 5.75e-04 | 11 | 114 | 2 | 15186747 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 6.37e-04 | 440 | 114 | 7 | 34244565 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 6.73e-04 | 211 | 114 | 5 | 24097068 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 6.73e-04 | 211 | 114 | 5 | 17314511 | |
| Pubmed | 6.88e-04 | 12 | 114 | 2 | 21344388 | ||
| Pubmed | Mit1/Lb9 and Copg2, new members of mouse imprinted genes closely linked to Peg1/Mest(1). | 6.88e-04 | 12 | 114 | 2 | 10788617 | |
| Pubmed | 6.88e-04 | 12 | 114 | 2 | 17442300 | ||
| Pubmed | 6.88e-04 | 12 | 114 | 2 | 14557543 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 7.30e-04 | 736 | 114 | 9 | 29676528 | |
| Pubmed | 7.55e-04 | 453 | 114 | 7 | 29656893 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 7.82e-04 | 125 | 114 | 4 | 32891193 | |
| Pubmed | 7.82e-04 | 125 | 114 | 4 | 29467281 | ||
| Pubmed | 8.11e-04 | 13 | 114 | 2 | 29499138 | ||
| Pubmed | 8.11e-04 | 13 | 114 | 2 | 30760716 | ||
| Pubmed | Crucial and Overlapping Roles of Six1 and Six2 in Craniofacial Development. | 8.11e-04 | 13 | 114 | 2 | 30905259 | |
| Pubmed | 8.11e-04 | 13 | 114 | 2 | 23277359 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 8.47e-04 | 462 | 114 | 7 | 31138677 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 8.65e-04 | 754 | 114 | 9 | 33060197 | |
| Pubmed | RAPGEF6 SETX OBSCN COPG2 ZNF318 CUBN FCHO2 ZNF595 UNC5C SFXN3 CEP295 | 8.87e-04 | 1084 | 114 | 11 | 11544199 | |
| Pubmed | Expression profiles of active genes in human and mouse livers. | 9.45e-04 | 14 | 114 | 2 | 8863742 | |
| Pubmed | 9.45e-04 | 14 | 114 | 2 | 29273440 | ||
| Pubmed | Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation. | 9.45e-04 | 14 | 114 | 2 | 26166704 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 9.95e-04 | 475 | 114 | 7 | 31040226 | |
| Pubmed | 1.05e-03 | 233 | 114 | 5 | 37704626 | ||
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | 1.07e-03 | 624 | 114 | 8 | 33729478 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SETX RBM33 COPG2 ZNF318 TASOR2 YEATS2 BRCA2 MDC1 KLK9 SPATA22 | 1.20e-03 | 954 | 114 | 10 | 36373674 |
| Pubmed | 1.24e-03 | 16 | 114 | 2 | 16511601 | ||
| Pubmed | 1.24e-03 | 16 | 114 | 2 | 23903356 | ||
| Pubmed | 1.24e-03 | 16 | 114 | 2 | 27760317 | ||
| Pubmed | 1.24e-03 | 16 | 114 | 2 | 24633704 | ||
| Pubmed | Smad4 is required to regulate the fate of cranial neural crest cells. | 1.24e-03 | 16 | 114 | 2 | 17964566 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.29e-03 | 497 | 114 | 7 | 36774506 | |
| Pubmed | The interactome of the prostate-specific protein Anoctamin 7. | 1.29e-03 | 65 | 114 | 3 | 32176628 | |
| Pubmed | 1.40e-03 | 17 | 114 | 2 | 31315026 | ||
| Pubmed | 1.40e-03 | 17 | 114 | 2 | 15511637 | ||
| Pubmed | 1.40e-03 | 17 | 114 | 2 | 22411303 | ||
| Pubmed | 1.50e-03 | 149 | 114 | 4 | 25184681 | ||
| Pubmed | 1.57e-03 | 18 | 114 | 2 | 32845237 | ||
| Pubmed | 1.57e-03 | 18 | 114 | 2 | 9152011 | ||
| Pubmed | Fgf8 dosage determines midfacial integration and polarity within the nasal and optic capsules. | 1.57e-03 | 18 | 114 | 2 | 23201021 | |
| Pubmed | 1.57e-03 | 18 | 114 | 2 | 16054041 | ||
| Pubmed | Gestational folate deficiency alters embryonic gene expression and cell function. | 1.57e-03 | 18 | 114 | 2 | 33302058 | |
| Pubmed | 1.58e-03 | 515 | 114 | 7 | 31617661 | ||
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | LYPD4 SMG1 SETX ENPP3 DPPA2 COPG2 DGKD ZNF217 ZNF318 CUBN TASOR2 BRCA2 MDC1 CEP295 POLD3 WNK3 MYBL1 | 9.35e-07 | 820 | 109 | 17 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_200 | 3.41e-05 | 36 | 109 | 4 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k3_200 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | DENND2A MYO10 OBSCN ADCY5 RYR2 AFAP1L2 UNC5C PLCB1 DOCK6 SH3RF3 | 3.19e-11 | 183 | 110 | 10 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | DENND2A DDR2 OBSCN ADCY5 RYR2 AFAP1L2 UNC5C PLCB1 DOCK6 SH3RF3 | 3.95e-11 | 187 | 110 | 10 | 62759efb660179402fb574ce5701c89a2e17bcfe |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | DENND2A MYO10 DDR2 OBSCN ADCY5 RYR2 AFAP1L2 UNC5C PLCB1 DOCK6 | 4.62e-11 | 190 | 110 | 10 | 4eb92aef1ee868f4537483d19014d947b7684612 |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | DENND2A MYO10 DDR2 OBSCN ADCY5 RYR2 AFAP1L2 UNC5C PLCB1 DOCK6 | 4.62e-11 | 190 | 110 | 10 | 7be4341e2909101d756f14031c21e705eb45e69a |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.38e-10 | 178 | 110 | 9 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.40e-10 | 181 | 110 | 9 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.87e-10 | 187 | 110 | 9 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-09 | 188 | 110 | 9 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.08e-09 | 189 | 110 | 9 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-09 | 197 | 110 | 9 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-09 | 197 | 110 | 9 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.14e-08 | 172 | 110 | 8 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.01e-08 | 185 | 110 | 8 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.19e-08 | 187 | 110 | 8 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.91e-08 | 194 | 110 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.15e-08 | 196 | 110 | 8 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.68e-08 | 200 | 110 | 8 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.68e-08 | 200 | 110 | 8 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 2.32e-07 | 171 | 110 | 7 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.51e-07 | 173 | 110 | 7 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.67e-07 | 183 | 110 | 7 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-07 | 184 | 110 | 7 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 3.95e-07 | 185 | 110 | 7 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.10e-07 | 186 | 110 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.90e-07 | 191 | 110 | 7 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.90e-07 | 191 | 110 | 7 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.45e-07 | 199 | 110 | 7 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.45e-07 | 199 | 110 | 7 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.67e-07 | 200 | 110 | 7 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.67e-07 | 200 | 110 | 7 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.67e-07 | 200 | 110 | 7 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.67e-07 | 200 | 110 | 7 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.91e-06 | 160 | 110 | 6 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-06 | 160 | 110 | 6 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-06 | 160 | 110 | 6 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.01e-06 | 161 | 110 | 6 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.91e-06 | 181 | 110 | 6 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.49e-06 | 184 | 110 | 6 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.90e-06 | 186 | 110 | 6 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.90e-06 | 186 | 110 | 6 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 188 | 110 | 6 | ed11e26ff4ef3d6314b5f5734062519b9aa285c1 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 188 | 110 | 6 | e5a8ca4613ab0bf1584b9e78959adf41d0bf379f | |
| ToppCell | facs-Heart-LV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 188 | 110 | 6 | 0fc3a6562e6895f6fe7a93397eae842a75c60c93 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.57e-06 | 189 | 110 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.80e-06 | 190 | 110 | 6 | 10125091ad648163777b02e9f0d5e8d7f17d44a5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.80e-06 | 190 | 110 | 6 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.80e-06 | 190 | 110 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | facs-Aorta-Heart-18m-Endothelial-aortic_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-06 | 193 | 110 | 6 | 7b7fecd332d3c99b8810bd7e14ab33aab46f2ffd | |
| ToppCell | facs-Aorta-Heart-18m-Endothelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-06 | 193 | 110 | 6 | 7170cbaef0ba1b65cab89c5d4ce525e6c04e4418 | |
| ToppCell | facs-Aorta-Heart-18m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-06 | 193 | 110 | 6 | 348a89bbf5fe7f7c875300c9ec3cb245c37e1308 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.53e-06 | 193 | 110 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.53e-06 | 193 | 110 | 6 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 8.53e-06 | 193 | 110 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 8.78e-06 | 194 | 110 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 8.78e-06 | 194 | 110 | 6 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 9.04e-06 | 195 | 110 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.86e-06 | 198 | 110 | 6 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 199 | 110 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 110 | 6 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 110 | 6 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 110 | 6 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.29e-05 | 156 | 110 | 5 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.42e-05 | 157 | 110 | 5 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-05 | 166 | 110 | 5 | 43f84d3cd58e93ce00c241656c4cba27604b4932 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.93e-05 | 167 | 110 | 5 | 881f64db8dea3faa7588bf04d87c20924a4e5952 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.27e-05 | 169 | 110 | 5 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 6.27e-05 | 169 | 110 | 5 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.45e-05 | 170 | 110 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 6.82e-05 | 172 | 110 | 5 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 7.60e-05 | 176 | 110 | 5 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / Disease condition and Cell class | 7.81e-05 | 177 | 110 | 5 | 8eb69041f482b58325e3539f607923f7b1fa5977 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 7.81e-05 | 177 | 110 | 5 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-05 | 178 | 110 | 5 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.23e-05 | 179 | 110 | 5 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.23e-05 | 179 | 110 | 5 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.23e-05 | 179 | 110 | 5 | 56db12467b445f2b8ef92af50779eeab10413eb2 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.45e-05 | 180 | 110 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | Endothelial-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 8.45e-05 | 180 | 110 | 5 | 4c3376169770ee9f9283daae44c17f35e46bfd19 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.67e-05 | 181 | 110 | 5 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.67e-05 | 181 | 110 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 8.90e-05 | 182 | 110 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 183 | 110 | 5 | 5a936fb07074cec753bf19e3e3e52499605ea22c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 183 | 110 | 5 | 07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-05 | 184 | 110 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 9.37e-05 | 184 | 110 | 5 | ed266bd2d12f86e8786473e64fbcd58319cd4c2a | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.61e-05 | 185 | 110 | 5 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 186 | 110 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 187 | 110 | 5 | ddfc2d1d9fcc3d8e4d3d015576bb17eebf44ada9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 187 | 110 | 5 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.04e-04 | 188 | 110 | 5 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 188 | 110 | 5 | 0026c9479b30fb39daa91cfa220a88f9c9e65fe7 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 188 | 110 | 5 | 40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.04e-04 | 188 | 110 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 188 | 110 | 5 | ba7f7ce034c0f42742bf2461f68f8d343ee593a5 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 189 | 110 | 5 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| Disease | CAKUT (is_implicated_in) | 3.90e-05 | 3 | 107 | 2 | DOID:0080205 (is_implicated_in) | |
| Disease | Cleft Lip with or without Cleft Palate | 1.29e-04 | 5 | 107 | 2 | C0810364 | |
| Disease | Unilateral agenesis of kidney | 3.60e-04 | 8 | 107 | 2 | C0266294 | |
| Disease | tonsillectomy risk measurement | 3.80e-04 | 260 | 107 | 6 | EFO_0007924 | |
| Disease | platelet component distribution width | DENND2A NRIP1 RTTN DUSP19 CUBN ADCY5 BCL6B AFAP1L2 PLCB1 ATP13A3 | 4.28e-04 | 755 | 107 | 10 | EFO_0007984 |
| Disease | Cleft palate with cleft lip | 4.61e-04 | 9 | 107 | 2 | C0158646 | |
| Disease | cervical carcinoma | 5.40e-04 | 182 | 107 | 5 | EFO_0001061 | |
| Disease | platelet crit | DENND2A NRIP1 KIF26A RTTN SUSD3 DGKD ZNF318 CUBN ADCY5 BANP PLCB1 | 6.88e-04 | 952 | 107 | 11 | EFO_0007985 |
| Disease | IGFBP-1 measurement | 9.90e-04 | 13 | 107 | 2 | EFO_0005118 | |
| Disease | alkaline phosphatase measurement | ACACB NOC2L ENPP3 ZNF318 FCHO2 PKD1L3 ADCY5 ITPKB TNKS PRR14L ALPK2 | 1.16e-03 | 1015 | 107 | 11 | EFO_0004533 |
| Disease | cleft lip (is_implicated_in) | 1.33e-03 | 15 | 107 | 2 | DOID:9296 (is_implicated_in) | |
| Disease | Pancreatic carcinoma | 2.14e-03 | 19 | 107 | 2 | C0235974 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.60e-03 | 157 | 107 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | small cell lung carcinoma | 3.11e-03 | 80 | 107 | 3 | EFO_0000702 | |
| Disease | BMI-adjusted fasting blood glucose measurement | 3.14e-03 | 23 | 107 | 2 | EFO_0008036 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 3.18e-03 | 166 | 107 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | Diuretic use measurement | 3.39e-03 | 169 | 107 | 4 | EFO_0009928 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TRIPCLLAPSVFKAS | 431 | Q8N9N5 | |
| FKPLVCISPNASLFD | 126 | P54619 | |
| LNSSVTVPLQSCIKP | 371 | O71037 | |
| SALNPSQPPSFLCKT | 216 | Q8TC20 | |
| KTSKAASFPQLPLDC | 96 | O95076 | |
| LCDPSAPLAFLQASK | 126 | O14514 | |
| PLCFLSTLLSQKVPE | 11 | Q86TB3 | |
| FTSKTPSISCVPNLI | 911 | Q9H7F0 | |
| TSNPTPAVLCFRVKN | 586 | Q0JRZ9 | |
| TLPARLNFPSVQKVC | 26 | A8K2U0 | |
| LNFPSVQKVCLDLSP | 31 | A8K2U0 | |
| CTPVNSATTLKNRPL | 781 | Q8N4X5 | |
| VNFIPTGSAFCPVKL | 451 | Q86VQ1 | |
| SLPQIPCLSSFKIHQ | 571 | Q9UHI6 | |
| SCVKLFPSPLQTLSR | 811 | O95622 | |
| VNSVNSSIPKACCVP | 361 | P12644 | |
| LPSCLPALASSQVKR | 26 | Q96D70 | |
| CSATPSAQVKPIVSA | 726 | Q96EV2 | |
| NCSLTPHVPFKLVST | 386 | Q9UN73 | |
| ISCFANVPKDTPLFS | 1386 | O00763 | |
| KTVFLRCTVNSNPPA | 151 | Q8NFP4 | |
| PPILKLACADTSANV | 181 | Q8NGN3 | |
| PIIFALSNPTSKAEC | 401 | P48163 | |
| DCSVALPFPSISKQH | 61 | Q14676 | |
| FLAKVNGTTPCAFPT | 291 | O15479 | |
| KAPASGICFSPVNEL | 206 | Q8NHV4 | |
| FSLAALPAKPENISC | 16 | Q8NI17 | |
| TNAGCTLVALNPFKP | 66 | Q96H55 | |
| PILSSAKAQVNPAIC | 16 | Q16832 | |
| KASVLAPLFSSCGPQ | 781 | Q7Z3E5 | |
| TTQPVVSPKCLTSAL | 1726 | Q5HYC2 | |
| NAKNPTSARLPLTFC | 2176 | Q5CZC0 | |
| SKSAPSIPKENFSCL | 141 | P40925 | |
| AALSLQLPFCKPQTT | 146 | A0A1B0GTH6 | |
| LSSSNPFFVRCIKPN | 626 | Q9HD67 | |
| SPKPSVACSQLALLL | 256 | P48552 | |
| VNSFLPPACLAEAAV | 236 | Q9ULI4 | |
| KDCLPNFVTTNSCPL | 151 | Q6UWN0 | |
| NSLPPAVVGCASKAL | 296 | O75600 | |
| LDSLPPVIKFCTSAA | 86 | Q8NFH4 | |
| VRNCKFTSPGALPFI | 341 | Q9Y3T9 | |
| LNSSLTVPLQSCVKP | 1131 | P63135 | |
| APKPVSVACTQLAFS | 1101 | Q8WXE0 | |
| LQAGQLSCISFPPKE | 86 | Q6XUX3 | |
| SICPAAATFQVALSP | 4701 | Q5VST9 | |
| FPPLLSLACKDTSAN | 181 | Q8NGY6 | |
| LGKFCTTFSVPPLQT | 661 | O60494 | |
| KAFLQFTTGCSTLPP | 2536 | Q9ULT8 | |
| LSPTAATVQFKCGAP | 256 | Q8N143 | |
| DPSQALPVIFGKSSC | 581 | Q96HP0 | |
| ICTFVSPAAQKAFQP | 3286 | P51587 | |
| KCVLNFPASPTSSIP | 396 | Q9ULE3 | |
| LNSSLTVPLQSCVKP | 371 | P61570 | |
| LNSSLTVPLQSCVKP | 371 | Q69384 | |
| VSKFSVCGFANPLPT | 556 | O14638 | |
| ALQLPKQCTFRFPST | 181 | P85037 | |
| APAVSVLQLFCSSPK | 286 | Q9UBF2 | |
| CKSASIPLTVVAFIP | 326 | Q9NQR9 | |
| VKDSNQACLPPSSFI | 401 | O60336 | |
| PIIFALSNPTSKAEC | 436 | Q16798 | |
| PSCTSPLLVFVNSKS | 316 | Q16760 | |
| VSSPKALFPVTLQCA | 151 | Q9UKQ9 | |
| APAVSVLQLFCSSPK | 286 | Q9Y678 | |
| LNSSLTVPLQSCVKP | 371 | Q902F9 | |
| NSSLIRKFPQPTLVC | 6686 | Q8NDH2 | |
| QKVFTFLKNSCPPTS | 146 | P59796 | |
| PSCHLIIPTFQDKSL | 1136 | Q9C0D2 | |
| PNKTPVAAICLTSLV | 356 | A0AV02 | |
| LCFLESTSNSKNVPP | 46 | Q92736 | |
| PSFTSTPICGQKALI | 506 | P10243 | |
| AVQPKALNSCSIPVS | 196 | Q7Z7J5 | |
| ASSNCPTLNIKPVSL | 726 | Q5THK1 | |
| SSLSAPLPKLCVFVT | 1596 | Q86VV8 | |
| PKTPFCFVINALSQR | 76 | Q9HB19 | |
| PLKICLPSVVNFFAA | 501 | Q9NYV6 | |
| KCRTIASLLTAAPNP | 276 | Q9H987 | |
| TCAKLRLPPQATFQV | 31 | Q96L08 | |
| PASLSSNLVACVPSK | 1551 | Q8TEU7 | |
| VFATPLCCALFPQKS | 276 | Q9BWM7 | |
| TLQPTKQPNCSSLFK | 501 | Q8N7P1 | |
| RSTAGCLPVPLFNQK | 11 | Q8NHS9 | |
| NKTDPCTLQFLAAPI | 296 | P09917 | |
| FLRKACSPSNIPAVI | 556 | P27987 | |
| CANALTSPPKVIRTF | 1001 | Q96Q15 | |
| SKTLCHPISQFPSVL | 196 | Q7Z443 | |
| KFKAPPCNTFVDLTS | 596 | Q7Z333 | |
| SQPCSKASIGLFVPA | 21 | Q9Y6E7 | |
| KPLTKSQPCLTSFNS | 536 | Q93073 | |
| TAPINKKQPFVCSSL | 576 | Q8IYB8 | |
| KFSAIQCAAAVPRAP | 131 | Q15054 | |
| PQKASLPSACVFLSL | 656 | Q9NZP6 | |
| CFTASKAESLIPGPA | 196 | Q9NWW5 | |
| AAKPPAICSPFSQDL | 71 | Q8IYB9 | |
| SPAFPSLIKNTGVAC | 511 | Q5TZJ5 | |
| VLQKLQDPCPSSLAS | 506 | Q9NX95 | |
| LATSRTAPAAKNPCL | 181 | Q8TEJ3 | |
| QPSPLALLAATCSKI | 31 | Q02086 | |
| SILSFCTSAIQKPPT | 206 | O76061 | |
| LPTCFKPQATVVSAS | 961 | O95271 | |
| CEAFPKAVLAPSAIL | 261 | Q96DN2 | |
| PLKICLPSVVNFFAA | 126 | Q2M238 | |
| AECAFKTSPFPILLS | 396 | Q9NQ66 | |
| FTSAILPICLPSVTK | 126 | Q7RTY5 | |
| LSVLNQCRKAFSLPP | 61 | P58317 | |
| NCPAISLSKSLIPSI | 696 | O75362 | |
| SGFLLANPFKITCEP | 1601 | Q01118 | |
| VPCSQAPAKAQSALT | 621 | Q5VWN6 | |
| GTSCLPDTFTKLINP | 1701 | Q12789 | |
| AFSIPLPIRQKLCSS | 841 | O95185 | |
| FEAKLTPCPQCSAVL | 321 | Q9H091 | |
| NLPIPSTVLRKSCSA | 1351 | Q5VUA4 | |
| AFQPIASSCKIVPQS | 426 | Q9ULM3 | |
| TCQVTSFLAFSKPSP | 601 | O43156 | |
| SCAAAASVVNPTPLL | 61 | A6NJT0 | |
| KSPAPTQASQICLLL | 51 | Q96M85 | |
| FGLSFTCPSLKNPIS | 1251 | Q9BYP7 | |
| AFSLVKNARPSICPN | 176 | Q8WTR2 | |
| PQSSLVIPTSLFCKT | 271 | Q02108 | |
| CSFANPLPSVKITQV | 51 | Q15223 |